BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 7992687)

  • 21. The frequency of fragile X syndrome among selected patients at Songklanagarind Hospital during 1991-1996, studied by cytogenetic and molecular methods.
    Jinorose U; Vasiknanonte P; Limprasert P; Brown WT; Panich V
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():69-74. PubMed ID: 9640603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Girls with fragile X syndrome: physical and neurocognitive status and outcome.
    Hagerman RJ; Jackson C; Amiri K; Silverman AC; O'Connor R; Sobesky W
    Pediatrics; 1992 Mar; 89(3):395-400. PubMed ID: 1741210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnosis and frequency of X-linked conditions in a cohort of moderately retarded males with affected brothers.
    Fishburn J; Turner G; Daniel A; Brookwell R
    Am J Med Genet; 1983 Apr; 14(4):713-24. PubMed ID: 6682625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of mental status in carriers of the fragile X mutation using CGG repeat length.
    Smits A; Smeets D; Hamel B; Dreesen J; de Haan A; van Oost B
    Am J Med Genet; 1994 Jul; 51(4):497-500. PubMed ID: 7943027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathology of unstable sequence of genome: fragile-X-syndrome].
    Beldjord C; Richard L
    C R Seances Soc Biol Fil; 1992; 186(4):363-70. PubMed ID: 1301224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of 53 fragile X families with the probe StB12.3.
    Puissant H; Malinge MC; Larget-Piet A; Martin D; Chauveau P; Odent S; Plessis G; Parent P; Lemarec B; Larget-Piet L
    Am J Med Genet; 1994 Dec; 53(4):370-3. PubMed ID: 7864047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
    Moore CJ; Daly EM; Tassone F; Tysoe C; Schmitz N; Ng V; Chitnis X; McGuire P; Suckling J; Davies KE; Hagerman RJ; Hagerman PJ; Murphy KC; Murphy DG
    Brain; 2004 Dec; 127(Pt 12):2672-81. PubMed ID: 15483045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Segregation of the fragile X mutation from a male with a full mutation: unusual somatic instability in the FMR-1 locus.
    Kambouris M; Snow K; Thibodeau S; Bluhm D; Green M; Feldman GL
    Am J Med Genet; 1996 Aug; 64(2):404-7. PubMed ID: 8844092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome].
    Chiurazzi P; Neri G
    Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fragile X male with a broad smear on Southern blot analysis representing 100-500 CGG repeats and no methylation at the EagI site of the FMR-1 gene.
    Lachiewicz AM; Spiridigliozzi GA; McConkie-Rosell A; Burgess D; Feng Y; Warren ST; Tarleton J
    Am J Med Genet; 1996 Aug; 64(2):278-82. PubMed ID: 8844065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular and genetic features of fragile X syndrome].
    Jara L; AvendaƱo I; Aspillaga M; Blanco R
    Rev Med Chil; 1996 Jul; 124(7):865-72. PubMed ID: 9138377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE.
    Parrish JE; Oostra BA; Verkerk AJ; Richards CS; Reynolds J; Spikes AS; Shaffer LG; Nelson DL
    Nat Genet; 1994 Nov; 8(3):229-35. PubMed ID: 7874164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The fragile X syndrome.
    Brown WT
    Neurol Clin; 1989 Feb; 7(1):107-21. PubMed ID: 2646518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A complex mutable polymorphism located within the fragile X gene.
    Zhong N; Dobkin C; Brown WT
    Nat Genet; 1993 Nov; 5(3):248-53. PubMed ID: 8275089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fragile X syndrome: current knowledge].
    Pellissier MC; Voelckel MA; Mattei JF
    Pediatrie; 1992; 47(11):743-50. PubMed ID: 1364151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragile X syndrome.
    de la Cruz FF
    Am J Ment Defic; 1985 Sep; 90(2):119-23. PubMed ID: 3901755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of the common fragile site at Xq27.2 under conditions of thymidylate stress: implications for cytogenetic diagnosis of the fragile-X syndrome.
    Ramos FJ; Emanuel BS; Spinner NB
    Am J Med Genet; 1992 Apr; 42(6):835-8. PubMed ID: 1532475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Butyrate and acetyl-carnitine inhibit the cytogenetic expression of the fragile X in vitro.
    Pomponi MG; Neri G
    Am J Med Genet; 1994 Jul; 51(4):447-50. PubMed ID: 7943015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.